Stratmann, Jan <br/><br/>
Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure.  [electronic resource] 

 -  Leukemia research  10 2019 
 - 106192 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-5835 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2019.106192  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Leukemia, Myeloid, Acute--diagnosis<br/>Male<br/>Melphalan--administration & dosage<br/>Proportional Hazards Models<br/>Recurrence<br/>Retreatment<br/>Treatment Failure<br/>Treatment Outcome